AlloVir, Inc.
AlloVir, Inc. (ALVR) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
alvr · stock forecast · 8 analysts (3M) · FMP · updated May 31, 2026
Analyst Rating & Consensus
Based on 8 Wall Street analysts in the past 3 months
Buy
8 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $9.81
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $9.72 | ↓ 0.95% |
1-day model range: $9.56–$9.87. Peak: $9.87 (-0.95%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -7.6% |
| 2028 | — | -11.2% |
| 2029 | — | -12.9% |
| 2030 | — | -13.7% |
| 2031 | — | -14.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · ALVR · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-12-26 | B of A Securities | Downgrade ↓ | Buy→Underperform |
| 2023-12-22 | JP Morgan | Downgrade ↓ | Overweight→Underweight |
| 2023-12-22 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2023-12-22 | Piper Sandler | Downgrade ↓ | Overweight→Neutral |
| 2023-08-07 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2023-08-06 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2023-04-26 | SVB Securities | Maintains | Outperform→Outperform |
| 2023-04-25 | SVB Securities | Maintains | Outperform→Outperform |
| 2023-01-27 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2023-01-26 | Morgan Stanley | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on AlloVir, Inc. (ALVR) stock. Of the recent 42 rating actions, 0 were upgrades and 4 were downgrades. 8 analysts currently cover ALVR.
Analyst Recommendation Trends
ALVR analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$64M
↓ 59.8% YoY
Revenue Next Year
$3M
↓ 95.9% YoY
EPS This Year
$-9.66
EPS Next Year
$-7.36
↓ 23.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast ALVR EPS of $-9.66 for the current fiscal year, based on estimates from 1 analysts. The ALVR revenue forecast is $64M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ALVR stock forecast is supported by two independent data sources: analyst consensus ratings from 8 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ALVR price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The ALVR short-term stock prediction for tomorrow is $9.72 (-0.95%). The ALVR stock prediction for 2030 projects a range of $8–$9.
AlloVir, Inc. trades on NASDAQ under the ticker ALVR. The ALVR stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
ALVR forecast · 8 questionsAccording to 8 Wall Street analysts, the average 12-month ALVR price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $9.81.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.